Urinary incontinence. Stress incontinence (female) (male)
Conditions
Interventions
Intervention 1: Control group: This group receives only routine exercises to strengthen the pelvic floor muscles, each session is 30 minutes and is divided into three parts: 1) Sustained contractions:
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women aged 35 to 70 years with urinary incontinence as the main clinical complaint, without urgent symptoms Urine loss of more than 1 gram per hour should be confirmed by a one-hour test pad The simultaneous presence of sexual disorders and impotence with urinary incontinence Absence of chronic degenerative diseases that affect muscle and nerve tissues Absence of any degree of pelvic organ prolapse (POP) Absence of active or recurrent urinary tract infections (UTIs) Absence of vulvovaginitis Absence of atrophic vaginitis Absence of copper IUD in the uterus Absence of pregnancy or childbirth less than 6 months Not suffering from diabetes, neurological disease, mental illness, and debilitating chronic diseases such as kidney failure and heart pacemakers. Absence of taking drugs that affect urination No history of surgical or drug treatment of SUI No history of abdominal and inguinal hernia No history of any surgery in the abdomen and pelvis (due to adhesions in the area and impact on the bladder) Absence of constipation No history of seizures
Exclusion criteria
Exclusion criteria: Having a urinary infection History of cesarean section Unwillingness to cooperate Suffering from chronic degenerative diseases that affect muscle and nerve tissues Presence of any degree of pelvic organ prolapse (POP) Presence of active or recurrent urinary tract infections (UTIs) Presence of vulvovaginitis Presence of atrophic vaginitis Presence of a copper IUD in the uterus Pregnancy or childbirth less than 6 months Having diabetes, neurological disease, mental illness and debilitating chronic diseases such as kidney failure and heart pacemaker Presence of drugs that affect urination History of surgical or drug treatment of SUI History of abdominal and inguinal hernia Having a history of any surgery in the abdomen and pelvis (due to adhesions in the area and impact on the bladder) Presence of constipation History of seizures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of urinary incontinence and vaginal symptoms. Timepoint: Before and after the intervention and one month after the last treatment session. Method of measurement: International Consultation on Incontinence Questionnaire Vaginal Symptoms Module questionnaire.;The volume of urine loss. Timepoint: Before and after the intervention and one month after the last treatment session. Method of measurement: One hour pad test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bladder displacement amount. Timepoint: Before and after the intervention and one month after the last treatment session. Method of measurement: Ultrasonography.;Strength and endurance of pelvic floor muscles. Timepoint: Before and after the intervention and one month after the last treatment session. Method of measurement: Perineometer.;Strength and endurance of pelvic floor muscles. Timepoint: Before and after the intervention and one month after the last treatment session. Method of measurement: Manual assessment with the Oxford scale.;Strength and endurance of pelvic floor muscles. Timepoint: Before and after the intervention and one month after the last treatment session. Method of measurement: Biofeedback. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Miri Torbaghan
Semnan University of Medical Sciences
Outcome results
None listed